- Areas of Research
- Grant Resources
- Research Experience for Medical Students (REMS)
- Research Centers
- Center for Comparative Effectiveness Analytics
- Center for Health Promotion and Prevention Research (CHPPR)
- Center of Biomedical Research Excellence (COBRE)
- North Dakota IDeA Network of Biomedical Research Excellence (INBRE)
- Rural Health Reform Policy Research Center
- Seven Generations Center of Excellence in Native Behavioral Health
- Clinical Centers
- Service Centers
- Center for Rural Health
- Fetal Alcohol Syndrome Center
- Health Workforce Information Center (HWIC)
- Mobile Simulation (SIM-ND)
- National Resource Center on Native American Aging
- North Dakota Area Health Education Center (AHEC)
- North Dakota Tobacco Quitline
- Rural Assistance Center (RAC)
- Rural Surgery Support Program
- Simulation Center (ND STAR)
- About Us
- New Building
- National Institutes of Health
- National Institute of General Medical Sciences
- Center for Protease Research
- Center for Visual and Cognitive Neuroscience
COBRE Center for Neurodegenerative Disorder Research
COBRE, an acronym for Centers of Biomedical Research Excellence, was designed by the National Institutes of Health (NIH) to cultivate research expertise among junior faculty and strengthen the research infrastructure of states that do not receive as much NIH funding as some large states.
In 2002, the University of North Dakota School of Medicine and Health Sciences received a $10.4 million, five-year award from the NIH to establish a nationally recognized Center of Biomedical Research Excellence (COBRE I).
The grant was renewed in 2007 for another five-year period at $10.1 million (COBRE II).
In 2012, the grant was renewed for another five years at $5.1 million. This portion of the grant focuses on core facilities rather than projects (COBRE III).
UND's COBRE funding supports collaborative projects promoting research opportunities for biomedical investigators in North Dakota. These projects offer broad potential for understanding and treating pathophysiological and neurodegenerative diseases, and also provided funds to establish Imaging and Mass Spectrometry facilities.
Funded by an Institutional Development Award (IDeA) from the National Institutes of Health, grant number 5P30GM103329.